EMA Annual Report: 114 new medicines in 2024
The European Medicines Agency (EMA) – the EU’s drug safety watchdog – approved 114 medicines last year, with 46 of these having a new active substance which had […]
ADVERTISMENT
The European Medicines Agency (EMA) – the EU’s drug safety watchdog – approved 114 medicines last year, with 46 of these having a new active substance which had […]
April was a bumper month for drug approvals in Europe, with sixteen new products recommended by the European Medicines Agency’s (EMA) key committee on human medicines. This almost […]
29th EAHP Congress highlights Anticholinergic burden (AB) or anticholinergic load (AL) refers to the cumulative effect of taking multiple medications with anticholinergic actions, which can lead to adverse effects, […]
29th EAHP Congress highlights Prescribing by hospital pharmacists is now well-established in a number of countries and there is evidence that stakeholders take a positive view of this […]
29th EAHP Congress highlights Medication review, with input from pharmacy, is a national standard for post- intensive care (ICU) follow-up, set out in the Guidelines for the Provision […]
29th EAHP Congress highlights Cigarette smoking is a well-recognised risk factor for stroke and measures to reduce the prevalence of cigarette smoking have been implemented in many countries. […]
29th EAHP Congress highlights Approximately 10% of inpatients are labelled as ‘allergic to penicillin’ but the vast majority have not experienced a true allergic reaction. Having a penicillin […]
29th EAHP Congress highlights Biopharmaceuticals are complex biological molecules that require careful storage and handling to ensure medication integrity. They are especially sensitive to mechanical stress and shaking, […]
The European Medicines Agency (EMA) has recommended four new products for approval, and extended the use of sixteen other drugs. The decisions, which brings to 12 the total […]
Tapinarof 1% cream (Vtama) has been approved by the Food and Drug Administration (FDA) for the treatment of atopic dermatitis (AD, eczema) in adults and children of two […]
Marsha Showman and Reena Patel (Leeds Health and Care Partnership) presented a poster describing how utilisation of health services was improved when people with long term conditions, including […]
In his keynote lecture Richard Cattell, Deputy Chief Pharmaceutical Officer, asked pharmacists to do three things: Make their voices heard in the development of the NHS 10-year plan […]